tofacitinib

Ukraine

Drugs containing this active substance

  • XELJANZ

    The drug is prescribed for the treatment of active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, as well as polyarticular juvenile idiopathic arthritis in children weighing 40 kg or more.

    Form: tablets, film-coated

    Active substance Dosage
    tofacitinib 5 mg

    ATC: L04AF01

    Manufacturer: Pfizer Manufacturing Deutschland GmbH (full-cycle manufacturing)

  • XELJANZ

    The drug is intended for the treatment of adults with active rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who have not achieved an adequate response to standard therapy.

    Form: tablets, extended-release

    Active substance Dosage
    tofacitinib 11 mg

    ATC: L04AF01

    Manufacturer: Pfizer Manufacturing Deutschland GmbH (testing, packaging, batch release)